BR100 Decreased By (-0.28%)
BR30 Decreased By (-0.09%)
KSE100 Decreased By (-0.23%)
KSE30 Decreased By (-0.29%)
AGHA 7.75 Decreased By ▼ -0.06 (-0.77%)
BECO 5.18 Decreased By ▼ -0.03 (-0.58%)
BML 57.55 Increased By ▲ 0.05 (0.09%)
BOP 34.46 Increased By ▲ 0.43 (1.26%)
CNERGY 10.01 Increased By ▲ 0.05 (0.5%)
CSIL 5.33 Increased By ▲ 0.02 (0.38%)
FCCL 54.54 Decreased By ▼ -0.16 (-0.29%)
FFL 16.56 Decreased By ▼ -0.13 (-0.78%)
FNEL 1.24 Increased By ▲ 0.01 (0.81%)
KEL 7.30 Decreased By ▼ -0.10 (-1.35%)
KOSM 5.80 Increased By ▲ 0.03 (0.52%)
LOTCHEM 29.35 Increased By ▲ 0.03 (0.1%)
MLCF 93.84 Decreased By ▼ -0.52 (-0.55%)
NBP 201.90 Decreased By ▼ -1.15 (-0.57%)
NCPL 57.20 Increased By ▲ 0.20 (0.35%)
NPL 67.70 No Change ▼ 0.00 (0%)
OGDC 316.49 Increased By ▲ 0.65 (0.21%)
PACE 10.60 Decreased By ▼ -0.04 (-0.38%)
PAEL 42.90 Decreased By ▼ -0.30 (-0.69%)
PIBTL 16.64 Decreased By ▼ -0.10 (-0.6%)
PPL 218.99 Decreased By ▼ -0.79 (-0.36%)
PRL 50.38 Increased By ▲ 1.19 (2.42%)
PTC 70.50 Decreased By ▼ -0.03 (-0.04%)
SSGC 27.75 Decreased By ▼ -0.50 (-1.77%)
TBL 9.78 Decreased By ▼ -0.08 (-0.81%)
TELE 8.73 Decreased By ▼ -0.06 (-0.68%)
TPL 18.55 Increased By ▲ 0.31 (1.7%)
TPLP 13.62 Increased By ▲ 0.35 (2.64%)
TREET 22.70 Decreased By ▼ -0.02 (-0.09%)
TRG 60.20 Increased By ▲ 0.06 (0.1%)
Business & Finance

EU preparing orders for 1.8bn vaccine booster shots

  • The planned orders will be for so-called mRNA vaccines, with a preference for manufacturers who are EU-based or who have production facilities in Europe.
  • Only the Biontech/Pfizer vaccine, which is manufactured in Belgium and Germany, and Moderna, which manufactures in Spain and Switzerland, currently meet these requirements.
Published Updated
By

BERLIN: The European Union will shortly sign contracts to purchase up to 1.8 billion doses of coronavirus vaccine to cover the bloc's need for booster shots over the coming two years, German daily Die Welt reported on Friday.

The newspaper said that contracts would be signed for deliveries of 900 million doses, with further contracts creating an option for another 900 million doses to be bought. The planned purchases would also cover the 70-80 million children in the EU, who are not currently being vaccinated.

The planned orders will be for so-called mRNA vaccines, with a preference for manufacturers who are EU-based or who have production facilities in Europe.

Only the Biontech/Pfizer vaccine, which is manufactured in Belgium and Germany, and Moderna, which manufactures in Spain and Switzerland, currently meet these requirements.

Comments

Comments are closed for this article.